Intermittent cholecalciferol supplementation in children and teenagers followed in pediatric nephrology: data from a prospective single-center single-arm open trial
- 24 December 2019
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Pediatrics
- Vol. 179 (4), 661-669
- https://doi.org/10.1007/s00431-019-03553-y
Abstract
Vitamin D deficiency is frequent in pediatric nephrology. The 2017 European guidelines recommend keeping 25OH vitamin D (25-D) levels within the 75–120 nmol/L range, ideally with daily supplementation. Intermittent supplementation with D3 has also been proposed. We aimed to assess the influence of our local protocol of intermittent vitamin D supplementation on the evolution of 25-D levels between baseline and 2 months. VITATOL is a prospective single-center study performed in our tertiary unit in children and teenagers followed for chronic kidney disease (CKD), kidney transplantation, or stable chronic nephrotic syndrome with 25-D levels below 75 nmol/L. Intermittent oral cholecalciferol (100,000 IU) was administered depending on baseline vitamin D levels and body weight. The primary outcome was the change in 25-D levels between baseline and 2 months. Secondary outcomes were the evolution of the main mineral biomarkers. Thirty-seven patients were included. Two months after beginning supplementation, corresponding to a median(min-max) of 46 (14–79) days after the last dose of vitamin D, 25-D levels increased from 50 to 76 nmol/L (p < 0.001), 18 patients having 25-D levels within the target range and 2 above. All patients displayed 25-D levels above 50 nmol/L. There were no significant changes in phosphate, PTH, alkaline phosphatase, and FGF23 levels before and after supplementation. Calcium levels increased from 2.39 to 2.44 mmol/L (p = 0.017), but no differences in calciuria and urinary calcium/creatinine ratio were observed. Conclusion: This vitamin D supplementation protocol using intermittent moderate doses of cholecalciferol seems efficient in 54% of cases, with neither significant overdose nor hypercalciuria. What is Known: • Vitamin D deficiency is frequent in pediatric nephrology. • The 2017 European guidelines recommend keeping 25OH vitamin D levels within the 75–120 nmol/L range ideally with daily supplementation, but intermittent supplementation with D3 has also been proposed. What is New: • We assessed the influence of a local protocol of intermittent vitamin D supplementation on the evolution of 25-D levels between baseline and 2 months in children and teenagers followed in pediatric nephrology. • The intermittent cholecalciferol supplementation protocol seems efficient in 54% of cases, with neither significant overdose nor hypercalciuria.Keywords
Funding Information
- Crinex laboratories (3000 euros)
This publication has 30 references indexed in Scilit:
- Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysisThe American Journal of Clinical Nutrition, 2012
- Vitamin D2 versus vitamin D3 supplementation in hemodialysis patients: a comparative pilot studyJournal of Nephrology, 2012
- Cardiovascular Disease in Children with Chronic Kidney DiseaseJournal of the American Society of Nephrology, 2012
- Ergocalciferol Supplementation in Children with CKD Delays the Onset of Secondary HyperparathyroidismClinical Journal of the American Society of Nephrology, 2012
- Update in Vitamin DJournal of Clinical Endocrinology & Metabolism, 2010
- KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 UpdateAmerican Journal of Kidney Diseases, 2009
- Effects of vitamin D supplementation on the calcium–phosphate balance in renal transplant patientsKidney International, 2009
- Vitamin D deficiency in children with renal diseaseArchives of Disease in Childhood, 2008
- Vitamin D insufficiency and hyperparathyroidism in children with chronic kidney diseasePediatric Nephrology, 2008
- 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin systemJCI Insight, 2002